I may be wrong but i have a strong feeling that vaxinia is a dud, hence y they havent updated for more than an year now. Goal post has been moving on that one (I say may be becoz if it is a dud y would FDA wasting time on this one?????)...... Azercell has become the front runner and is very well on track and in the scheme of things. But a problem with that is, every time we achieve a milestone we have an obligation with milestone payments to precesion. Feels like salary has not credited yet there are 10 bills with a due date on the salary date.
In my opinion the management are moving to onCARlytics study now wont be surprised if they put mast study on the back burner like they did with Bcell.
Any ways iam hanging in there as I see 2025 is make or not believe a word of management year for me. Dyor spidey.
IMU Price at posting:
4.1¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)